Suppr超能文献

相似文献

1
4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes-2023.
Diabetes Care. 2023 Jan 1;46(Suppl 1):S49-S67. doi: 10.2337/dc23-S004.
2
4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes-2024.
Diabetes Care. 2024 Jan 1;47(Suppl 1):S52-S76. doi: 10.2337/dc24-S004.
4
3. Prevention or Delay of Diabetes and Associated Comorbidities: Standards of Care in Diabetes-2024.
Diabetes Care. 2024 Jan 1;47(Suppl 1):S43-S51. doi: 10.2337/dc24-S003.
6
17. Diabetes Advocacy: Standards of Care in Diabetes-2023.
Diabetes Care. 2023 Jan 1;46(Suppl 1):S279-S280. doi: 10.2337/dc23-S017.
7
7. Diabetes Technology: Standards of Care in Diabetes-2023.
Diabetes Care. 2023 Jan 1;46(Suppl 1):S111-S127. doi: 10.2337/dc23-S007.
8
6. Glycemic Targets: Standards of Care in Diabetes-2023.
Diabetes Care. 2023 Jan 1;46(Suppl 1):S97-S110. doi: 10.2337/dc23-S006.
9
4. Comprehensive Medical Evaluation and Assessment of Comorbidities: .
Diabetes Care. 2021 Jan;44(Suppl 1):S40-S52. doi: 10.2337/dc21-S004.
10
2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023.
Diabetes Care. 2023 Jan 1;46(Suppl 1):S19-S40. doi: 10.2337/dc23-S002.

引用本文的文献

2
Adaptation of Risk Score for Hepatocellular Carcinoma Without Alcohol Measures.
JAMA Netw Open. 2025 Jul 1;8(7):e2522305. doi: 10.1001/jamanetworkopen.2025.22305.
3
Discrete Choice Experiments and Conjoint Analyses in Health Screening Programs for Type 2 Diabetes and Liver Disease: A Scoping Review.
Can Liver J. 2025 Feb 25;8(1):63-78. doi: 10.3138/canlivj-2024-0050. eCollection 2025 Feb.
7
Predictors of smoking abstinence among diabetic smokers: Evidence from the French national smoking cessation registry CDTnet.
PLoS One. 2025 Jun 20;20(6):e0321764. doi: 10.1371/journal.pone.0321764. eCollection 2025.
8
Semaglutide: a key medication for managing cardiovascular-kidney-metabolic syndrome.
Future Cardiol. 2025 Jul;21(9):663-683. doi: 10.1080/14796678.2025.2511412. Epub 2025 Jun 3.

本文引用的文献

1
"It Just Kind of Feels Like a Different World Now:" Stress and Resilience for Adolescents With Type 1 Diabetes in the Era of COVID-19.
Front Clin Diabetes Healthc. 2022 Feb 21;3:835739. doi: 10.3389/fcdhc.2022.835739. eCollection 2022.
2
Semaglutide 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial.
Lancet Gastroenterol Hepatol. 2023 Jun;8(6):511-522. doi: 10.1016/S2468-1253(23)00068-7. Epub 2023 Mar 16.
3
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease.
Hepatology. 2023 May 1;77(5):1797-1835. doi: 10.1097/HEP.0000000000000323. Epub 2023 Mar 17.
4
Diabetes and cirrhosis: Current concepts on diagnosis and management.
Hepatology. 2023 Jun 1;77(6):2128-2146. doi: 10.1097/HEP.0000000000000263. Epub 2023 Jan 13.
5
Impacts of the COVID-19 Pandemic on Pediatric Type 1 Diabetes Management: A Qualitative Study.
Sci Diabetes Self Manag Care. 2022 Dec;48(6):522-532. doi: 10.1177/26350106221125701. Epub 2022 Sep 24.
7
Management of NAFLD in primary care settings.
Liver Int. 2022 Nov;42(11):2377-2389. doi: 10.1111/liv.15404. Epub 2022 Sep 1.
8
Improving Quality Outcomes: The Value of Diabetes Care and Education Specialists.
Clin Diabetes. 2022 Summer;40(3):356-365. doi: 10.2337/cd21-0089.
9
The Impact of the COVID-19 Pandemic on Ethnic Minority Groups With Diabetes.
Diabetes Care. 2023 Feb 1;46(2):228-236. doi: 10.2337/dc21-2495.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验